← Back to Search

Working Memory Training for Cognitive Impairment in Older Adults

N/A

Waitlist Available

Led By Aaron R Seitz, Phd

Research Sponsored by Northeastern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 25, day 47, day 79

Awards & highlights

No Placebo-Only Group

Summary

This trial will help to determine how different types of working memory training programs can be tailored to optimize outcomes in older adults.

Who is the study for?

This trial is for older adults aged 50-85 who speak English and can follow the study's procedures. They must not have psychological or neurological conditions that affect consent, be involved in other memory studies, or have certain cognitive impairments as measured by specific tests.

What is being tested?

The study examines how different working memory training methods affect older adults. It uses a randomized crossover design to test gamified vs non-gamified tasks and multisensory vs visual-only information to see which improves learning based on individual cognitive abilities.

What are the potential side effects?

Since this is a non-medical intervention focusing on working memory training, typical medical side effects are not expected. However, participants may experience mental fatigue or frustration during challenging cognitive tasks.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 25, day 47, day 79

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 25, day 47, day 79

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 25, day 47, day 79 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Corsi span

Change in Everyday Memory Questionnaire Revised

Change in Inhibitory Control Composite Score

+1 more

Secondary study objectives

Exit Survey

Training Experience Difficulty Subscale I

Training Experience Difficulty Subscale II

+6 more

Other study objectives

Change in General Cognitive Ability Composite Score

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Active Control

Group I: Condition 1Active Control3 Interventions

Training type 1 will be administered in the first part of the crossover trial and Training type 2 will be administered in the second part of the trial. Each training part consists of 20 twenty-minute long sessions with the recommended frequency of 2 sessions per work day. Thus each training part can be completed in 10 work days (2 weeks).

Group II: Condition 2Active Control3 Interventions

Training type 2 will be administered in the first part of the crossover trial and Training type 1 will be administered in the second part of the trial. Each training part consists of 20 twenty-minute long sessions with the recommended frequency of 2 sessions per work day. Thus each training part can be completed in 10 work days (2 weeks).

Do I qualify?Apply below to find out